European public procurement and grants data from official registers · Data as of 18 November 2026; updated daily.

Tenders

Cardiovascular drug tenders in France

Cardiovascular drug tenders in France: 373 listed on GranTender since 2024; 1 open now. The median awarded contract value is about €1,300,000 (42 contracts with a stated value). Buyers with the most tenders: Centre Hospitalier Universitaire Caen Normandie (147), CHU Rouen Normandie (137) and Centre Hospitalier Universitaire de Reims, en qualité d'établissement support du Groupement Hospitalier Universitaire de Champagne (GHUC) (55); suppliers with the most contract awards: Abbott Medical France (26), Takeda France (25) and LFB Biomedicaments (24). Sources: DECP, BOAMP and TED. In 2025 the median contract value was €390,000; 1% of contracts drew a single bid (69.7 bids on average). Data as of 18 November 2026; updated daily.

Tenders
373
Open tenders
1
Awards
439
Awarded value awarded
€322,274,598
Awarded value contract
€748,487,204
Awarded value framework ceiling
€341,621,598
Median contract value contract
≈ €410,000
Median contract value awarded
≈ €1,300,000
Median contract value framework ceiling
≈ €1,600,000
Average bids per contract
51.1
Tenders in 2025
210 +1,300% on 2024

Median: contracts with a stated value, rounded. Average bids: contracts where the number of bids is published.

Value kinds: awarded — the value in the award decision; contract — the value of the signed or amended contract; paid — the amount actually paid; framework ceiling — the maximum of a framework agreement, given with every winner, not money spent. Different kinds are never added together.

Open tenders

TenderBuyerEstimated valueStatusPublished
UNIHA Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie GéniqueHospices Civils de Lyon—Open19 November 2025

Latest tenders

TenderBuyerEstimated valueStatusPublished
Fourniture de RYPLAZIM® (PLASMINOGEN, HUMAN-TVMH) sous autorisation d'accès compassionnelCHU de Lille - ES du GHT HPGL—Awarded1 October 2026
Fourniture des traitements nécessaires à l’étude BOLEROCHRU de Tours—Closed17 July 2026
FOURNITURE DE MEDICAMENTS DU SEGMENT « SANG ET ORGANES HEMATOPOIETIQUES » POUR LE GROUPEMENT DE COMMANDES REGIONAL DE BRETAGNE29 CHRU—Closed26 June 2026
HEPARINE STANDARD CALCIQUE INJCHU de Toulouse—Awarded19 May 2026
HEPARINE STANDARD SODIQUE INJCHU de Toulouse—Awarded19 May 2026
Tubes à prélèvement de sang sous vide en polymère pour dosage d oligo éléments héparine de sodiumCHU de Toulouse—Awarded7 April 2026
FOURNITURE DE MEDICAMENTS DU SEGMENT « SANG ET ORGANES HEMATOPOIETIQUES » POUR LE GROUPEMENT DE COMMANDES REGIONAL DE BRETAGNE29 CHRU—Closed5 April 2026
Fourniture de dispositifs médicaux cicatrisation contention immobilisation lots 1 bas jarret anti-thrombose et 2 bas cuisse anti-thromboseCHR Metz-Thionville—Awarded1 April 2026
HEPARINE STANDARD CALCIQUE INJCHU de Toulouse—Awarded25 March 2026
Fourniture d'Isoprénaline Injectable pour les besoins de 6 établissements du GHT Normandie CentreCentre Hospitalier Universitaire Caen Normandie€139,581Awarded13 March 2026
Tubes anticoagulants specifiques EFSCHU de Toulouse—Awarded6 March 2026
Fourniture d'Isoprénaline Injectable pour les besoins de 6 établissements du GHT Normandie CentreCentre Hospitalier Universitaire Caen Normandie—Awarded3 March 2026
UNIHA Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie GéniqueHospices Civils de Lyon—Open19 November 2025
TLS02-2026- M_3427 -FER INJECTABLE-CARBOXYMALTOSE FERRIQUECentre Hospitalier Universitaire de Reims, en qualité d'établissement support du Groupement Hospitalier Universitaire de Champagne (GHUC)—Awarded10 November 2025
FOURNITURE DE MEDICAMENTS DU SEGMENT « SANG ET ORGANES HEMATOPOIETIQUES » POUR LE GROUPEMENT DE COMMANDES REGIONAL DE BRETAGNE29 CHRU—Closed24 August 2025
Fourniture de médicaments dérivés du sang pour le CHU Rouen NormandieCHU Rouen Normandie—Awarded20 August 2025
La présente consultation a pour objet la fourniture de médicaments dérivés du sang pour le CHU Rouen Normandie. - FACTEUR VIII RECOMBINANT – TUROCTOCOG ALFACHU Rouen Normandie—Awarded4 August 2025
La présente consultation a pour objet la fourniture de médicaments dérivés du sang pour le CHU Rouen Normandie. - PROTEINE C HUMAINCHU Rouen Normandie—Awarded30 July 2025
La présente consultation a pour objet la fourniture de médicaments dérivés du sang pour le CHU Rouen Normandie. - PROTEINE C HUMAINCHU Rouen Normandie—Awarded30 July 2025
FOURNITURE DE MEDICAMENTS DERIVES DU SANG - MDSTG2025 M83106 - ASSOCIATION FVIII HUMAIN ET F WILLEBRAND HUMAIN A DOSES DIFFERENTESCentre Hospitalier Universitaire de Reims, en qualité d'établissement support du Groupement Hospitalier Universitaire de Champagne (GHUC)—Awarded1 July 2025

Competition and prices

In 2025, half of the contracts were worth between €100,000 and €1.8 million, with a median of €390,000 (204 contracts with a stated contract value). Contracts drew 69.7 bids on average (median 72) and 1% drew a single bid — based on 148 contracts with a known number of bids.

The most contracts went to Abbott Medical France (26), Takeda France (25) and LFB Biomedicaments (24) — together 17% of all contracts.

YearContractsMedian valueMiddle half of valuesBids on averageSingle bid
2025208€390,000 (contract value)€100,000 – €1.8 million69.71% (148)
2026 (so far)146€430,000 (contract value)€150,000 – €870,000——
All years439€410,000 (contract value)€120,000 – €1.3 million51.11% (224)

Values: contracts with a stated value in EUR, each value kind on its own (awarded or contract value), approximate (±3 %). Bids: contracts of procedures with competition whose number of bids the source publishes (1–100 bids); the sources publish it for some contracts only (TED ≈ 3 in 4, Spain all, Poland about half, Italy few), so each figure states its base and is shown from 20 contracts. A contract counts in the year of its award (else of its tender). Figures as of 13 November 2026, recomputed every week.

Where you have a chance

Since 1 November 2024, 2% of the 152 contracts with a known number of bids had a single bid; the median was 72 bids. The number of bids is known for 152 of the 353 contracts from procedures with competition.

In the last 12 months, 2 companies won their first contract in our records here — 1% of the 140 contracts (our records start on 1 January 2024).

Contracts awarded since 1 November 2024 (the last 24 months). Bids as the source publishes them, 1 to 100 per contract, in procedures with competition only (a direct award has one offer by design). As of 13 November 2026.

Main CPV divisions

CPV codes of this topic

  • 33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system

A tender belongs here when its main CPV code starts with one of these codes; a tender without a usable CPV code (or with a general one) is matched by words of its title. A tender may belong to up to three topics.

Cardiovascular and anticoagulant drugs in neighbouring countries

Today, 2 tenders in the same niche are open in neighbouring countries.

Public tenders in the EU and the EEA are open to companies from every EU and EEA country on the same terms as local ones, and to companies from countries with a procurement agreement with the EU (such as Switzerland, the United Kingdom and Ukraine) for the contracts it covers. Open means the deadline has not passed (today's date). Neighbours: countries with a land border, a fixed link or a short sea crossing.

Expected soon2

ExpectedBuyerWhatWhy we expect itConfidence
Dec 2026 – May 2027
contract ends
CHU de Lille - ES du GHT HPGLCardiovascular and anticoagulant drugs
Fourniture de RYPLAZIM® (PLASMINOGEN, HUMAN-TVMH) sous autorisation d'accès compassionnel
Typical value: ≈ €1.7m
The current contract with KEDRION BIOPHARMA INC ends on 18 June 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 10/2026
medium
Dec 2026 – May 2027
contract ends
Hopital Nord Ouest - Villefranche sur SaoneCardiovascular and anticoagulant drugs
UNIHA Fournitures de médicaments du segment « Médicaments antinéoplasiques et immunomodulateurs, immunosuppresseurs, facteurs de croissance hématopoïétiques » (dupliqué)
Typical value: ≈ €69,000
The current contract with SANDOZ ends on 19 June 2027 (from its stated duration); no new tender has been published yet.
Earlier tenders: 06/2024
high

Forecast from public data, not an announcement. Methodology.

Market reports

Cardiovascular and anticoagulant drugs by city

Cardiovascular and anticoagulant drugs in other countries

Cardiovascular and anticoagulant drugs across Europe

Topics in Health, medical equipment and medicines

Questions and answers

Which cardiovascular drug tenders in France are open now?
1 of the 373 cardiovascular drug tenders in France listed on GranTender is open for bids. For example: UNIHA Fourniture de Médicaments Dérivés du Sang, recombinants et issus de Thérapie Génique.
Where can I find cardiovascular drug tenders in France?
GranTender lists them in one place, from DECP, BOAMP and TED, with their buyers, winners and contract values; 1 is open now. Search in one country at a time (the first 5 results) is free; search across all countries at once, full result lists, saved keywords with an e-mail once a week and exports come with a plan.
Who wins the most cardiovascular drug tenders in France?
By number of contracts won: Abbott Medical France (26), Takeda France (25), LFB Biomedicaments (24).
Which buyers publish the most cardiovascular drug tenders in France?
By number of tenders: Centre Hospitalier Universitaire Caen Normandie (147), CHU Rouen Normandie (137), Centre Hospitalier Universitaire de Reims, en qualité d'établissement support du Groupement Hospitalier Universitaire de Champagne (GHUC) (55).
Which CPV codes belong to “Cardiovascular and anticoagulant drugs”?
33620000 Medicinal products for the blood, blood-forming organs and the cardiovascular system; plus tenders without a usable CPV code whose title names the topic.
How many bids do cardiovascular drug tenders in France receive on average?
In 2025, contracts drew 69.7 bids on average (median 72) and 1% drew a single bid — based on 148 contracts with a known number of bids.
How much are contracts for cardiovascular drug tenders in France worth?
In 2025, half of the contracts were worth between €100,000 and €1.8 million, with a median of €390,000 (204 contracts with a stated contract value).

CPV 2008 (Regulation (EC) No 213/2008), © European Union, Publications Office — via the eForms SDK, CC BY 4.0.